Riding Towards Hope: NMDP Cycle’s Nationwide Mission
A Journey of Compassion and Challenge On March 30, the NMDP Cycle, previously known as the Be The Match® Tour de TC, embarks on a transformative six-ride tour across the United States. This inspiring event is not just a test of endurance and strength but a beacon of hope for those awaiting life-saving blood stem […]
Revolutionizing Blood Health: The Ethical Maze of Stem Cell Therapy in Hematology
Welcome to our deep dive into the world of stem cell therapy in hematology. This emerging field is not just a beacon of hope for countless patients suffering from blood disorders, but also a realm teeming with ethical quandaries and moral dilemmas. Here, we’ll explore these complexities, aiming to shed light on the path that […]
Umbilical Cord Blood Stem Cells in Treating Blood Disorders
In recent years, the medical community has witnessed a surge in the interest and application of stem cell therapy, particularly in the realm of treating various health conditions. Among the various sources of stem cells, umbilical cord blood stem cells have emerged as a promising and potent option. In this article, we delve into the […]
Hematopoietic Stem Cell Transplantation (HSCT) for Leukemia: A Modern Lifeline
When faced with leukemia, a type of cancer that launches a stealthy and devastating attack on the body’s blood-forming tissues, patients and their families often feel as though they’ve been cast adrift in a tempestuous sea. However, amidst these turbulent waters, Hematopoietic Stem Cell Transplantation (HSCT) emerges as a life-saving beacon of hope, offering a […]
IN8bio Announces Major Advancements in Leukemia and Glioblastoma Treatments
On October 12, 2023, IN8bio, a pioneering clinical-stage biopharmaceutical company, made a significant announcement regarding its gamma-delta T cell therapies. The company has successfully completed the enrollment for its Phase 1 study of INB-100, a potential treatment for leukemia patients. This marks a significant step forward as INB-100 is being evaluated for its safety when […]
Be The Match Foundation’s Triumph: Over $327,000 Raised at the Annual Los Angeles Soirée
In a remarkable display of philanthropy and community spirit, the Be The Match Foundation® celebrated its annual Los Angeles Soirée on August 11 at the Skirball Cultural Center. This event, dedicated to supporting patients battling life-threatening blood cancers and disorders, witnessed an astounding collection of over $327,000 in a single night. A Night of Hope […]
Clinical Applications of Hematopoietic Stem Cells in Blood Cell Disorders
Welcome, dear readers, to our exploration of the fascinating world of stem cells. Today, we’re diving deep into a specific type of stem cell, known as the hematopoietic stem cell. Picture these cells as the master builders of our blood system, the architects that design and construct the various types of cells that flow through […]
Innovative Cell Therapy, Omisirge, Receives FDA Approval to Reduce Infection Risk in Blood Cancer Treatments
The FDA has approved Omisirge (omidubicel-onlv), a modified allogeneic cord blood-based cell therapy designed to speed up the recovery of neutrophils and reduce infection risk. Omisirge is intended for use in adults and pediatric patients aged 12 and older with blood cancers who are undergoing umbilical cord blood transplantation after a myeloablative conditioning regimen. Blood […]
A New Hope: Umbilical Cord Blood Stem Cells Expand Access to HIV Cures
Mixed-race woman with both HIV and acute leukemia received a stem cell transplant using umbilical cord blood stem cells with a CCR5-delta32 mutation, which confers resistance to HIV. This modified approach may expand the pool of available stem cells for curing HIV in people needing transplants for other medical conditions. The patient’s leukemia remains in […]
Father’s Gift of Life: Young Cancer Warrior Levi Triumphs with Dad’s Stem Cell Help
7-year-old Levi Galvez celebrated being cancer-free at Riley Hospital in Indianapolis on March 27, after a five-year battle with leukemia that began when he was two years old. His father, Geovani Galvez, provided a life-saving stem cell transplant a year ago. The family celebrated the milestone with cheers, laughter, and a small ceremony. Geovani, who […]